Category: esters-buliding-blocks

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Wu, Zijun; Wang, Jian researched the compound: (11bR)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide( cas:861909-53-7 ).Name: (11bR)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide.They published the article 《Enantioselective Medium-Ring Lactone Synthesis through an NHC-Catalyzed Intramolecular Desymmetrization of Prochiral 1,3-Diols》 about this compound( cas:861909-53-7 ) in ACS Catalysis. Keywords: enantioselective cyclization intramol desymmetrization prochiral diol heterocyclic carbene catalyst; lactone preparation. We’ll tell you more about this compound (cas:861909-53-7).

A highly enantioselective intramol. annulation reaction of 1,3-diols catalyzed by a triazolium N-heterocyclic carbene (NHC) precatalyst is disclosed, affording the corresponding medium-sized lactones in moderate to good yields with high enantioselectivities. It is worth noting that this compatible catalytic system was successfully applied to assemble a broad range of chiral medium-sized lactones, including ones with eight-, nine-, ten-, eleven-, and twelve-membered rings.

There are many compounds similar to this compound(861909-53-7)Name: (11bR)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide. if you want to know more, you can check out my other articles. I hope it will help you，maybe you’ll find some useful information.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II), is researched, Molecular C6H12N2O4Pt, CAS is 41575-94-4, about Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.Reference of cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II).

Few clin. studies have been designed for elderly patients with locally advanced non-small cell lung cancer (NSCLC). We conducted a phase I study to evaluate the tolerability of carboplatin/nab-paclitaxel and concurrent thoracic radiotherapy in elderly patients with locally advanced NSCLC. The eligibility criteria were: unresectable stage III NSCLC, performance status 0 or 1, and age ≥75 years. Eligible patients received 6 wk of weekly carboplatin/nab-paclitaxel and concurrent thoracic radiotherapy with a total dose of 64 Gy in 32 fractions. Carboplatin was fxed to an area under the plasma concentration time curve (AUC) of 2 mg/mL/min, and the recommended dose of nab-paclitaxel was evaluated using a dose-escalation study (30 or 40 mg/m2). Tolerability at the recommended dose was evaluated in an expansion study. Nineteen patients were enrolled at four institutions, all of whom were eligible and assessable. The recommended nab-paclitaxel dose was set at 30 mg/m2 because two patients experienced dose-limiting toxicity at 40 mg/m2. The treatment completion rate of the 17 patients analyzed at the recommended dose was 100% (80% confdence interval (CI), 83.8-100%). The overall response rate was 76.5%, and the median progression free survival was 13.4 mo (95% CI, 4.2-21.4 mo). Common grade 3 and 4 toxicities included leukopenia (23.5%), neutropenia (17.6%), anemia (5.9%), and infection (5.9%). One treatment-related death due to pneumonitis was observed six months after the end of the study. In conclusion, carboplatin/nab-paclitaxel and concurrent thoracic radiotherapy show good tolerability and exhibit promising efcacy in elderly patients with locally advanced NSCLC.

There are many compounds similar to this compound(41575-94-4)Reference of cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II). if you want to know more, you can check out my other articles. I hope it will help you，maybe you’ll find some useful information.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: 6-Bromo-8-methylquinoline(SMILESS: CC1=CC(Br)=CC2=C1N=CC=C2,cas:178396-31-1) is researched.Reference of cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II). The article 《Cobalt(III)-Catalyzed 1,4-Addition of C(sp3)-H Bonds to Maleimides》 in relation to this compound, is published in Synlett. Let’s take a look at the latest research on this compound (cas:178396-31-1).

In this manuscript, an efficient and atom-economic protocol for synthesis of addition products I (R = H, 7-OCH3, 5-Cl, etc.; R1 = Me, Et, Bn, 4-FC6H4, etc.) via alkylation reactions of 8-methylquinolines II with maleimides such as N-methylmaleimide, N-phenylmaleimide, N-benzylmaleimide, etc. is presented. The reaction exhibits exceptional reactivity, satisfactory yields, excellent chemo- and regioselectivity, and tolerates a variety of functional groups.

There are many compounds similar to this compound(178396-31-1)Related Products of 178396-31-1. if you want to know more, you can check out my other articles. I hope it will help you，maybe you’ll find some useful information.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine( cas:415918-91-1 ) is researched.Quality Control of (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine.Graening, Timm; Hartwig, John F. published the article 《Iridium-Catalyzed Regio- and Enantioselective Allylation of Ketone Enolates》 about this compound( cas:415918-91-1 ) in Journal of the American Chemical Society. Keywords: ketone chemoselective regioselective enantioselective preparation; chemoselective regioselective enantioselective substitution allylic carbonate silyl enol ether; stereoselective substitution allylic carbonate iridium phosphoramidite metallocyclic catalyst; cesium zinc fluoride catalyst stereoselective silyl enol ether allylation; formation iridium phosphoramidite metallocycle enantioselective substitution allylic carbonate enolate; regioselective enantioselective ketone enolate allylation allylic carbonate iridium phosphoramidite. Let’s learn more about this compound (cas:415918-91-1).

Regio- and enantioselective α-allylation of Me ketone silyl enol ethers RC(OSiMe3):CH2 (R = Ph, 2-MeOC6H4, Me2CH, PhCH2CH2) with unsym. allylic carbonates (E)-R1CH:CHCH2OC(:O)OCMe3 [R1 = 4-MeOC6H4, 4-F3CC6H4, 2-furyl, Me2CH, EtCH2, (E)-MeCH:CH] in the presence of iridium metallocycles derived from bis[(1,5-cyclooctadiene)iridium(I) chloride] and nonracemic phosphoramidites such as I (or its enantiomer), cesium fluoride, and zinc fluoride yields nonracemic branched ketones RCOCH2CHR1CH:CH2 [R = Ph, 2-MeOC6H4, Me2CH, PhCH2CH2; R1 = 4-MeOC6H4, 4-F3CC6H4, 2-furyl, Me2CH, EtCH2, (E)-MeCH:CH] in 46-94% yields, 85:15-99:1 regioselectivities, and in 91-96% ee. CsF and ZnF2 are both necessary for the allylation reactions; no reaction occurs in the absence of cesium fluoride while reaction with decreased regio- and chemoselectivity occurs in the absence of zinc fluoride. 31P NMR of iridium complexes of I and bis[(1,5-cyclooctadiene)iridium(I) chloride] indicate the presence of a (cyclooctadiene)(phosphoramidite)iridium chloride and of a metallocycle derived from a (cyclooctadiene)iridium bis(phosphoramidite) complex.

There are many compounds similar to this compound(415918-91-1)Quality Control of (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine. if you want to know more, you can check out my other articles. I hope it will help you，maybe you’ll find some useful information.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Electric Literature of C22H38NiO4. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)nickel(II), is researched, Molecular C22H38NiO4, CAS is 14481-08-4, about Catalyst enhanced chemical vapor deposition of nano-particle nickel films on Teflon surface. Author is Liu, Endong; Feng, Wenfang; Zhou, Jinlan; Yu, Kaichao.

Films formed with nanosized nickel particles on teflon surface were prepared by means of catalyst enhanced chem. vapor deposition (CECVD) with Ni(dmg)2, Ni(acac)2, Ni(hfac)2, Ni(TMHD)2, and Ni(cp)2 as precursors, and complexes Pd(hfac)2, PdCl2, and Pd(η3-2-methylallyl)acac as catalyst under carrier gas (H2). The film growth rate depends on the precursors and substrate temperature The chem. value, purity and surface morphol. of the Ni particle films were characterized by XPS and SEM. The films obtained were shiny with silvery color, and consisted of grains with a particle size of 50-140 nm. The Ni was metallic of which the purity was about 90-95% from XPS anal. SEM micrograph showed that the film had good morphol.

There are many compounds similar to this compound(14481-08-4)Electric Literature of C22H38NiO4. if you want to know more, you can check out my other articles. I hope it will help you，maybe you’ll find some useful information.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Electric Literature of C6H12N2O4Pt. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II), is researched, Molecular C6H12N2O4Pt, CAS is 41575-94-4, about Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer.. Author is Horiuchi, Minoru; Oguri, Tetsuya; Kagawa, Yusuke; Sone, Kazuki; Fukuda, Satoshi; Uemura, Takehiro; Takakuwa, Osamu; Maeno, Ken; Fukumitsu, Kennsuke; Kanemitsu, Yoshihiro; Tajiri, Tomoko; Ohkubo, Hirotsugu; Takemura, Masaya; Ito, Yutaka; Niimi, Akio.

BACKGROUND/AIM: The optimal chemotherapy for concurrent chemoradiotherapy (cCRT) of lung cancer is still unclear. PATIENTS AND METHODS: We investigated the therapeutic effect of different chemotherapy regimens for cCRT of lung cancer in 65 patients at our hospital. RESULTS: Of the 65 patients, 53 were male and 12 female. The median age was 64 years and 58 participants had a smoking history. The histological type was adenocarcinoma in 34 cases, squamous cell carcinoma in 22 cases, and others in 9 cases. Induction therapy consisted of cisplatin plus vinorelbine (CDDP+VNR) in 50 cases, and weekly carboplatin plus paclitaxel (CBDCA+PTX) in 15 cases. In all patients, the overall response rate, disease control rate, median progression survival, and median overall survival were 78.5%, 95.4%, 337 days, and 1,037 days, respectively. The median progression-free survival was 337 days in total; it was significantly longer for CDDP+VNR than CBDCA+PTX. The median overall survival was 1,037 days in total; it tended to be slightly longer for CDDP+VNR than CBDCA+PTX. CONCLUSION: Different chemotherapy regimens for cCRT possibly have different therapeutic effects.

Here is just a brief introduction to this compound(41575-94-4)Electric Literature of C6H12N2O4Pt, more information about the compound(cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)) is in the article, you can click the link below.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Cotton, F. Albert; Harris, Charles Bonner; Wise, John J. published an article about the compound: Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)nickel(II)( cas:14481-08-4,SMILESS:CC(C)(C1=O[Ni+2]2(O=C(C(C)(C)C)[CH-]1)O=C([CH-]C(C(C)(C)C)=O2)C(C)(C)C)C ).Product Details of 14481-08-4. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:14481-08-4) through the article.

Extended Hueckel-type M.O. calculations were carried out on bis(β-ketoenolate) complexes of Cu(II) and Ni(II), taking these as planar mols. of D2h symmetry, with the ring substituents as H atoms (to limit the size of the basis set of at. orbitals). The Wolfsberg-Helmholz approximation was used to estimate off-diagonal matrix elements. The diagonal matrix elements for the metal orbitals were estimated by the Ros procedure in which valence state ionization potentials are corrected (substantially) for the influence of the ligand atoms. The coefficient of the dxy orbital in 1 of the M.O.’s was constrained to have a value similar to that indicated by E.S.R. data by adjustment of the Hii terms of the O atoms. The results of the calculation are in good agreement with E.S.R. data and the visible spectra and are useful in interpreting uv spectra. 28 references.

Here is just a brief introduction to this compound(14481-08-4)Product Details of 14481-08-4, more information about the compound(Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)nickel(II)) is in the article, you can click the link below.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Safety of (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine, is researched, Molecular C36H30NO2P, CAS is 415918-91-1, about Palladium-Catalyzed Enantioselective Heteroarenyne Cycloisomerization Reaction. Author is Liang, Ren-Xiao; Song, Ling-Jie; Lu, Jin-Bo; Xu, Wei-Yan; Ding, Chao; Jia, Yi-Xia.

The extensively developed ene-type enantioselective cycloisomerization of classical 1,n-enynes provides an efficient approach to chiral cyclic 1,4-dienes. In contrast, the catalytic asym. heteroarenyne (heteroarene-alkyne) cycloisomerization involving the dearomative transformation of endocyclic aromatic C=C bonds remains unknown. Herein, we communicate a PdH-catalyzed enantioselective heteroarenyne cycloisomerization reaction of alkyne-tethered indole substrates (formal 1,5- and 1,6-enynes). Based on this strategy, a variety of structurally diverse chiral spiro and fused indoline derivatives bearing quaternary stereocenters and exocyclic C=C bonds are afforded in moderate to excellent yields and excellent enantioselectivities (up to 98% ee). The classical ene-type enantioselective 1,5-enyne cycloisomerization of N-vinylpropiolamides is also developed to afford chiral 2-pyrrolones in good to excellent ee values.

Here is just a brief introduction to this compound(415918-91-1)Safety of (11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine, more information about the compound((11bR)-N,N-Bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine) is in the article, you can click the link below.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Related Products of 41575-94-4. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II), is researched, Molecular C6H12N2O4Pt, CAS is 41575-94-4, about Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis. Author is Vidra, Radu; Nemes, Adina; Vidrean, Andreea; Pintea, Sebastian; Tintari, Snejeana; Deac, Andrada; Ciuleanu, Tudor.

Meta-anal. of the addition of platinum compounds to standard neoadjuvant chemotherapy (NACT) for triple-neg. breast cancer (TNBC) is highly controversial. Platinum agents, such as cisplatin and carboplatin, are DNA-damaging agents which exhibit activity in breast cancer, particularly in the TNBC subgroup. In order to assess the efficacy of each most representative platinum agent (cisplatin and carboplatin) in patients with TNBC treated with NACT, the present study performed a systematic review and meta-anal. of all available published studies on TNBC. A search of PubMed was performed to identify studies that investigated platinum-based NACT in patients with TNBC. The primary endpoints were the pooled rate of the pathol. complete response (pCR) between cisplatin vs. carboplatin-based NACT. A total of 24 studies were selected (17 studies for carboplatin and 6 studies for cisplatin and 1 study with both carboplatin and cisplatin, with 20 prospective studies) for the anal. of 1,711 patients with TNBC. Overall, the pooled rate of pCR in patients treated with platinum-based NACT was 48%. No significant differences were observed between the rates of pCR obtained under carboplatin vs cisplatin treatment. The carboplatin pCR rate was 0.470 [95% confidence interval (CI), 0.401-0.539], while the cisplatin pCR rate was 0.473 (95% CI, 0.379-0.568). The comparison between these two categories revealed no significant differences (P=0.959). In the whole, the present study demonstrates that neoadjuvant platinum-based chemotherapy improves the pCR rate in patients with TNBC, regardless of the platinum agent used. Carboplatin may thus represent a viable option due to its more favorable toxicity profile.

Here is just a brief introduction to this compound(41575-94-4)Related Products of 41575-94-4, more information about the compound(cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)) is in the article, you can click the link below.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Application of 178396-31-1. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 6-Bromo-8-methylquinoline, is researched, Molecular C10H8BrN, CAS is 178396-31-1, about Cobalt(III)/Rhodium(III)-Catalyzed Regio- and Stereoselective Allylation of 8-methylquinoline via sp3 C-H Activation.

Regio- and stereoselective benzylic allylation of 8-methylquinolines with (per)fluoroalkyl olefins was realized via benzylic C-H activation and subsequent C-F cleavage. Both cobalt(III) and rhodium(III) catalysts can effect this transformation in good to high efficiency. The Rh(III)-catalyzed system proceeded under moderate conditions with decent substrates scope, providing (Z)-alkenyl fluorides with good to excellent regio- and stereoselectivity.

Here is just a brief introduction to this compound(178396-31-1)Application of 178396-31-1, more information about the compound(6-Bromo-8-methylquinoline) is in the article, you can click the link below.

Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics